R&D at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Twist Bioscience Corporation's R&D?
- Twist Bioscience Corporation (TWST) reported R&D of $19.7M in Q1 2026.
- How has Twist Bioscience Corporation's R&D changed year-over-year?
- Twist Bioscience Corporation's R&D decreased by 17.7% year-over-year, from $23.92M to $19.7M.
- What is the long-term trend for Twist Bioscience Corporation's R&D?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's R&D has grown at a 3.8% compound annual growth rate (CAGR), from $69.07M to $80.29M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.